Medical Devices & Diagnostics · LP-211
Glucometer Medical device
Device / diagnostic development record. Review the proposed presentation and the professional reference information below.
Development record
- Portfolio reference
- LP-211Medical Devices & Diagnostics
- Product type
- GlucometerMedical device
- Registration
- Not establishedProduct-specific evidence required
- Availability
- Not marketedNo offer of supply
01 · Product-type reference
Record identity and reference background.
- Portfolio reference
- LP-211
- Product type
- Glucometer
- Device presentation
- Medical device
- Configuration / specification
- Meter device
- Proposed pack
- Retail carton with lancet device option
- Portfolio category
- Medical Devices & Diagnostics
About Glucometer
A glucometer is a diagnostic device used with compatible test strips to measure glucose in a specified blood sample. The meter, strip and sampling process form one measurement system. It does not deliver insulin or independently determine treatment. Intended user, setting, specimen and performance claims depend on the specific authorized model and cannot be established by a generic catalogue name.
How to read this profile
Scientific information relates to the device or diagnostic type. It is not approved Luang Pharma labelling, a clinical recommendation, or evidence of equivalence to a referenced product. Multiple strengths or presentations represent separate proposed variants and must not be treated as interchangeable.
02 · Professional background
Scientific & clinical reference
Read the clinical context, selected safety considerations and presentation-specific information below.
Intended-use context
Glucose monitoring can support diabetes care when linked to a defined management plan and training. Results need interpretation alongside symptoms, recent food, activity and other clinical factors. A home-use meter does not automatically meet requirements for professional use in all patient groups. The proposed product entry does not identify a model, so connectivity, memory, ketone capability and compatibility with particular strips remain unverified.
Important safety considerations
Incompatible or deteriorated strips, poor sampling, contamination and device-specific interferences can produce wrong results. Treating a misleading result can cause harm. A value inconsistent with symptoms should prompt review under the care plan. Lancing devices must not be shared between people, and professional multi-patient testing requires an appropriate device and infection-control process. Batteries and small components also need safe handling.
These are selected considerations, not a complete list. Use the current instructions or approved label for the exact authorised product and seek appropriate professional advice.
Presentation, handling and storage
The catalogue lists a meter with an optional lancing-device arrangement. Verify the exact meter-strip system, intended user, measurement units, specimen requirements, quality-control materials and supplied accessories. No accuracy certification or performance threshold is asserted.
Clean and disinfect only as the device instructions permit. Keep compatible strips within their own storage limits and use quality checks as directed. Do not share a personal lancing device. Retain model, serial and strip-lot information for service and traceability.
Final composition, instructions, shelf life and storage conditions are not established by this portfolio entry. They must come from the controlled documentation for the specific product.
Points for professional review
Confirm model-level registration, performance evidence, strip availability, training and maintenance. Establish the process for quality checks, unexpected readings, complaint reporting and ongoing supply.
03 · Product enquiry
Documentation & regulatory status
Evidence status
What is established — and what remains open
This record has received an editorial evidence-layer review. The review separates catalogue facts from unresolved product-specific fields and external context; it is not medical, regulatory or market-authorisation approval.
Layer 01
Controlled catalogue facts
- Device / diagnostic type
- Glucometer
- Presentation
- Medical device
- Catalogue configuration
- Meter device
- Catalogue pack
- Retail carton with lancet device option
- Portfolio category
- Medical Devices & Diagnostics
Layer 02
Unresolved product-specific fields
- P023 — The glucometer entry identifies no model or strip system. It therefore cannot be linked as compatible with LP-207 blood-glucose test strips until exact meter/strip manufacturer and model evidence is supplied.
- Meter accuracy, sample volume, coding/calibration, hematocrit/interference limits, connectivity, professional-versus-home use and regulatory status are all model-specific.
- Approved indication, patient eligibility and dosing or test interpretation are not established by this portfolio record.
- Registration/authorization, manufacturing or site status, supply availability, storage conditions and shelf life remain product- and market-specific evidence items.
Layer 03
Attributed external context
- FDA: Blood Glucose Monitoring Devicesgovernment medical-device guidance
These references provide scientific or regulatory context only. They are not Luang Pharma product labelling, registration, manufacturing evidence, equivalence evidence or confirmation of supply.
Layer 04
Documents required to close the record
- Exact meter model/IFU plus manufacturer evidence identifying the compatible test-strip system, sample requirements, performance specification, limitations and intended-use setting.
- Destination-market device/IVD classification and authorization/conformity evidence for the exact model; generic FDA/WHO references are not evidence for the Luang record.
- Model-specific quality/performance verification and current packaging/label artwork before any public certification, accuracy, sterility or compatibility claim.
- Manufacturing/supply-status evidence before any claim that the device is produced, stocked, registered or available through Luang Pharma.
For LP-211, identify the destination country, intended professional use, proposed presentation and the role of your organisation. The appropriate supply route and available documentation must be confirmed for that case.
- Confirm the legal entity, manufacturing site and authorised scope for the proposed supply chain.
- Confirm device classification, intended use, conformity evidence and local import requirements.
- Request relevant product information, specifications and supporting evidence through the company contact.
- Confirm storage, transport, traceability, complaints and safety-reporting responsibilities before any agreement.
The public catalogue extends beyond the initial planned facility modules. A listing does not mean that the dosage form is installed, qualified or licensed at Boten.
04 · External sources
Sources and further reading
External sources are provided for reference. Their authors do not endorse Luang Pharma, and another product’s authorisation does not transfer to this portfolio record. Source availability and wording can change.
Professional enquiries
Request product-specific evidence for LP-211.
State the exact presentation, organisation, destination and evidence needed. This public record is not an offer of supply.